BONESUPPORT™, a leading company in orthobiologics for the management of bone injuries, today announced that Emil Billbäck, CEO of BONESUPPORT, has sold 92,450 shares in BONESUPPORT.
After the sale, Emil Billbäck owns 344,230 shares and thus remains with a larger private ownership.
"The sale is made solely to cover tax obligations and I do not plan to sell additional shares. I have great confidence in BONESUPPORT's future prospects and look forward to continuing to develop the company", says Emil Billbäck, CEO of BONESUPPORT.
The transaction has been reported to the Swedish Financial Supervisory Authority in accordance with current regulations.